Personally, I'm very curious about the combination of homeopathic nosodes and biophotons. I have successfully treated several bugs, including lyme and co-infections, using this method granted I was able to procure a nosode series from European manufacturers. However, I have not heard of any anecdotes or studies using this treatment for HIV or any other retroviruses, although nosodes for HIV do exist. Several companies I've spoken with are eagerly trying to cooperate with a lab to manufacture the nosode, at which point I will certainly consider treating with it using my Bionic 880 photon machine.
In the meantime, here are a few prelim studies I pulled up on homeopathy and HIV:
Homeopathy in HIV infection: a trial report of double-blind placebo controlled study.
Rastogi DP, Singh VP, Singh V, Dey SK, Rao K.
Central Council for Research in Homoeopathy, JNBCHA, Janakpuri, New Delhi, India.
OBJECTIVE: This study was aimed to evaluate the immuno-modulator role of homeopathic remedies in Human Immunodeficiency Virus (HIV) infection. METHODOLOGY: A randomised double blind clinical trial was conducted to compare the effect of homeopathic remedies with placebo, on CD4+ve T-lymphocytes in HIV infected individuals, conforming to Centres for Disease Control (CDC) stage II & III. 100 HIV+ve individuals between 18-50 y (71% males) were included in the study. 50 cases conformed to CDC stage II--Asymptomatic HIV infection, and 50 cases to CDC stage III--Persistent Generalised Lymphadenopathy (PGL). Cases were stratified according to their clinical status and CD4+ve lymphocyte counts. The randomisation charts were prepared much before the start of the trial by randomly assigning placebo and verum codes to registration numbers from 1 to 50. A single individualised homeopathic remedy was prescribed in each case and was followed up at intervals of 15 d to one month. A six months study was performed for each registered case. Assessment of progress was made by evaluation of CD+ve lymphocyte counts, which was the prospectively-defined main outcome measure of the study; the results were compared with the base line immune status. RESULTS: In PGL, a statistically significant difference was observed in CD+ve T-lymphocyte counts between pre and post trial levels in verum group (P < 0.01). In the placebo group a similar comparison yielded non-significant results. (P = 0.91). Analysis of change in the pre and post trial counts of CD4+ve cells between groups was also statistically significant (P = 0.04). In asymptomatic HIV infection, differences in absolute CD4+ve lymphocyte counts between pre and post trial levels were not significant. Analysis of changes in pre and post trial CD4 levels of placebo and verum groups for combined strata of asymptomatic and PGL groups was also not significant. CONCLUSION: The study suggests a possible role of homeopathic treatment in HIV infection in symptomatic phase, as evidenced by a statistically significant elevation of base line immune status in persistent generalised lymphadenopathy.
http://www.ncbi.nlm.nih.gov/pubmed/10335412
Use of homeopathy for delaying progression of HIV disease.
Bhave G; International Conference on AIDS.
Int Conf AIDS. 1998; 12: 849 (abstract no. 42377).
OBJECTIVE: With 30 years experience in homeopathy, an attempt was made to study the effect of homeopathic treatment on the progression of HIV disease METHODS: Total 62 patients were referred for homeopathic treatment in last 5 years. All the patients had confirmed Western Blot report for HIV infection & were given post test counselling. Detailed case history was recorded as per homeopathic principles. The broad outline of the treatment included in chronological orders, medicines for psychological trauma & shock, for purification of the body, constitutional medicines & medicines for the prevention of opportunistic infections. Any other major or minor illnesses were treated with indicated homeopathic medicines. Two patients who developed tuberculosis were referred to chest physician. Date of infection was taken as year of first exposure to virus due to risk behaviour or due to blood transfusion. Only 26 patients could afford CD4 count and were referred to private laboratory. Method used was immunofluorescence. Patients were classified into three groups: 1) Asymptomatic 2) AIDS related conditions 3) AIDS. RESULTS: Majority of the patients, 91% were males & 9% were females. All the patients were between 25 to 44 age group. All the patients were educated. Four patients had HIV infection for more than 7 years and are asymptomatic. 88% of the patients with 5 to 7 years infection are asymptomatic, 80% of the patients gained weight from 2 to 6 kg. 78% of the patients had CD4 count more than 500 cells/cumm. 6 (10%) patients had ARC. One patient had severe diarrhoea, one had Herpes zoster and two had stomatitis and all of them responded well to homeopathic treatment. Two patients developed TB, one patient died due to TB. CONCLUSION: People from developing countries cannot afford costly antiviral therapy. Homeopathic medicines are easily available in India at a reasonable price and hence could be used for treatment of HIV disease.
http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102231175.html
In the meantime, here are a few prelim studies I pulled up on homeopathy and HIV:
Homeopathy in HIV infection: a trial report of double-blind placebo controlled study.
Rastogi DP, Singh VP, Singh V, Dey SK, Rao K.
Central Council for Research in Homoeopathy, JNBCHA, Janakpuri, New Delhi, India.
OBJECTIVE: This study was aimed to evaluate the immuno-modulator role of homeopathic remedies in Human Immunodeficiency Virus (HIV) infection. METHODOLOGY: A randomised double blind clinical trial was conducted to compare the effect of homeopathic remedies with placebo, on CD4+ve T-lymphocytes in HIV infected individuals, conforming to Centres for Disease Control (CDC) stage II & III. 100 HIV+ve individuals between 18-50 y (71% males) were included in the study. 50 cases conformed to CDC stage II--Asymptomatic HIV infection, and 50 cases to CDC stage III--Persistent Generalised Lymphadenopathy (PGL). Cases were stratified according to their clinical status and CD4+ve lymphocyte counts. The randomisation charts were prepared much before the start of the trial by randomly assigning placebo and verum codes to registration numbers from 1 to 50. A single individualised homeopathic remedy was prescribed in each case and was followed up at intervals of 15 d to one month. A six months study was performed for each registered case. Assessment of progress was made by evaluation of CD+ve lymphocyte counts, which was the prospectively-defined main outcome measure of the study; the results were compared with the base line immune status. RESULTS: In PGL, a statistically significant difference was observed in CD+ve T-lymphocyte counts between pre and post trial levels in verum group (P < 0.01). In the placebo group a similar comparison yielded non-significant results. (P = 0.91). Analysis of change in the pre and post trial counts of CD4+ve cells between groups was also statistically significant (P = 0.04). In asymptomatic HIV infection, differences in absolute CD4+ve lymphocyte counts between pre and post trial levels were not significant. Analysis of changes in pre and post trial CD4 levels of placebo and verum groups for combined strata of asymptomatic and PGL groups was also not significant. CONCLUSION: The study suggests a possible role of homeopathic treatment in HIV infection in symptomatic phase, as evidenced by a statistically significant elevation of base line immune status in persistent generalised lymphadenopathy.
http://www.ncbi.nlm.nih.gov/pubmed/10335412
Use of homeopathy for delaying progression of HIV disease.
Bhave G; International Conference on AIDS.
Int Conf AIDS. 1998; 12: 849 (abstract no. 42377).
OBJECTIVE: With 30 years experience in homeopathy, an attempt was made to study the effect of homeopathic treatment on the progression of HIV disease METHODS: Total 62 patients were referred for homeopathic treatment in last 5 years. All the patients had confirmed Western Blot report for HIV infection & were given post test counselling. Detailed case history was recorded as per homeopathic principles. The broad outline of the treatment included in chronological orders, medicines for psychological trauma & shock, for purification of the body, constitutional medicines & medicines for the prevention of opportunistic infections. Any other major or minor illnesses were treated with indicated homeopathic medicines. Two patients who developed tuberculosis were referred to chest physician. Date of infection was taken as year of first exposure to virus due to risk behaviour or due to blood transfusion. Only 26 patients could afford CD4 count and were referred to private laboratory. Method used was immunofluorescence. Patients were classified into three groups: 1) Asymptomatic 2) AIDS related conditions 3) AIDS. RESULTS: Majority of the patients, 91% were males & 9% were females. All the patients were between 25 to 44 age group. All the patients were educated. Four patients had HIV infection for more than 7 years and are asymptomatic. 88% of the patients with 5 to 7 years infection are asymptomatic, 80% of the patients gained weight from 2 to 6 kg. 78% of the patients had CD4 count more than 500 cells/cumm. 6 (10%) patients had ARC. One patient had severe diarrhoea, one had Herpes zoster and two had stomatitis and all of them responded well to homeopathic treatment. Two patients developed TB, one patient died due to TB. CONCLUSION: People from developing countries cannot afford costly antiviral therapy. Homeopathic medicines are easily available in India at a reasonable price and hence could be used for treatment of HIV disease.
http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102231175.html
.
